Sigma Planning Corp Trims Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sigma Planning Corp cut its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 8,387 shares of the medical equipment provider’s stock after selling 161 shares during the period. Sigma Planning Corp’s holdings in Intuitive Surgical were worth $4,378,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in ISRG. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $26,000. MidAtlantic Capital Management Inc. bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical during the fourth quarter valued at approximately $36,000. Capital Performance Advisors LLP bought a new stake in shares of Intuitive Surgical during the third quarter valued at approximately $38,000. Finally, DT Investment Partners LLC boosted its position in shares of Intuitive Surgical by 80.0% during the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock valued at $40,000 after purchasing an additional 36 shares in the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $591.79 on Friday. The stock has a market cap of $210.78 billion, a PE ratio of 92.32, a price-to-earnings-growth ratio of 5.85 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00. The stock has a fifty day moving average of $565.45 and a 200 day moving average of $525.06.

Wall Street Analysts Forecast Growth

ISRG has been the topic of several research reports. Evercore ISI lifted their price target on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. UBS Group boosted their target price on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a report on Friday, January 24th. Leerink Partners boosted their target price on Intuitive Surgical from $490.00 to $548.00 in a report on Monday, January 27th. Finally, Wells Fargo & Company boosted their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $613.10.

Insider Activity at Intuitive Surgical

In related news, CFO Jamie Samath sold 269 shares of the company’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at approximately $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Amal M. Johnson sold 4,635 shares of the company’s stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the sale, the director now owns 12,275 shares of the company’s stock, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by insiders.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.